Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Increased Intracranial Pressure ll: Pathophysiology01:29

Increased Intracranial Pressure ll: Pathophysiology

Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Endocannabinoid cerebrospinal fluid levels in migraine and its relation to symptoms of depression.

Cephalalgia : an international journal of headache·2026
Same author

From bench to bedside: relevant animal models across the migraine attack phases.

The journal of headache and pain·2026
Same author

Impact of cenobamate on cortical responses to transcranial magnetic stimulation in people with drug-resistant focal epilepsy.

Epilepsia open·2026
Same author

Visually-induced hemodynamic response and white matter hyperintensities in middle-aged women with ischemic stroke or migraine with aura.

Cephalalgia : an international journal of headache·2026
Same author

Tsunamis hiding in plain sight: spreading depression in clinical neurology.

Nature reviews. Neurology·2026
Same author

Cerebral collateral arteriogenesis and cerebrovascular reserve in aged and diet-induced obese mice after unilateral common carotid occlusion.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism·2026

関連する実験動画

Updated: May 26, 2026

Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache
05:40

Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache

Published on: July 29, 2021

片頭痛の変異は,イシュケミアの脱極化を促進することによって,脳卒中の脆弱性を高めます.

Katharina Eikermann-Haerter1, Jeong Hyun Lee, Izumi Yuzawa

  • 1Stroke and Neurovascular Regulation Laboratory, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA.

Circulation
|December 7, 2011
PubMed
まとめ

ファミリアル・ヘミプレジック・ミグレーン (FHM) 変異は,脳を不全性イベントに対してより脆弱にすることで,脳卒中のリスクを高めます. 脳の脱極化に対するこの高い感受性は,より大きな脳卒中とより悪い結果につながります.

さらに関連する動画

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

関連する実験動画

Last Updated: May 26, 2026

Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache
05:40

Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache

Published on: July 29, 2021

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

科学分野:

  • 神経科学は神経科学である.
  • 遺伝学 遺伝学とは
  • 脳卒中研究 卒中研究

背景:

  • 片頭痛は脳卒中のリスク因子として知られていますが,その背後にあるメカニズムは不明です.
  • 家族性半麻痺性片頭痛 (FHM) は,共通の特徴とメカニズムがあるため,一般的な片頭痛の貴重なモデルとして機能します.
  • FHMは脳卒中のリスクの増加と関連しています.

研究 の 目的:

  • FHM型1 (FHM1) 変異が,脳内不全性脳卒中に対する脆弱性に対する影響を調査する.
  • FHMと脳卒中リスクを結びつける細胞および生理学的メカニズムを解明する.

主な方法:

  • 2つのFHM1変異マウス株と野生型のコントロールを使用しました.
  • アノキシカルデポラライゼーションとペリインファクトデポラライゼーションを用いて脳活動を評価した.
  • 分散加重型MRIとレーザースペックルフローメトリーを使用して,定量化された心臓発作のサイズと神経学的アウトカム.
  • グルタミン酸受容体アンタゴニストの効果を調査した.

主要な成果:

  • FHM1の変異により,突然変異したマウスでは,早期の無酸素脱極化と,より頻繁な周辺心臓発作脱極化が発生した.
  • ミュータントマウスは,急激な心臓発作の核心拡張とより大きな輸血不足を示した.
  • ミュータントマウスは,生存のためにより高い脳血流を必要とし,軽度のイシュケミアの心臓発作につながった.
  • ミュータントマウスはより大きな心臓発作と悪質な神経学的アウトカムを発症し,これはグルタミン酸受容体抗体治療によって軽減された.

結論:

  • うつ病の蔓延に類似した,不血性脱極化に対する感受性の向上は,軽度の不血性イベント中にミグレーナーを心臓発作に誘導します.
  • このメカニズムは,片頭痛患者の脳卒中リスクの増加に寄与しています.
  • グルタマタージックメカニズムを標的にすることは,感受性の高い個体において脳卒中予防のための治療的可能性を提示する可能性があります.